tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

OTLK Stock Latest News

Outlook Therapeutics price target lowered to $10 from $12 at Guggenheim
The FlyOutlook Therapeutics price target lowered to $10 from $12 at Guggenheim
3d ago
OTLK
Positive Outlook on Outlook Therapeutics: Buy Rating Supported by Strategic Launches and Market Opportunities for Lytenava
PremiumRatings
Positive Outlook on Outlook Therapeutics: Buy Rating Supported by Strategic Launches and Market Opportunities for Lytenava
4d ago
OTLK
Outlook Therapeutics price target lowered to $3 from $30 at H.C. Wainwright
PremiumThe Fly
Outlook Therapeutics price target lowered to $3 from $30 at H.C. Wainwright
4d ago
OTLK
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
OTLK
Outlook Therapeutics Reports Strong Earnings and Strategic Progress
PremiumCompany Announcements
Outlook Therapeutics Reports Strong Earnings and Strategic Progress
7d ago
OTLK
Outlook Therapeutics reports Q1 adjusted EPS (89c) vs. (78c) last year
PremiumThe FlyOutlook Therapeutics reports Q1 adjusted EPS (89c) vs. (78c) last year
8d ago
OTLK
Outlook Therapeutics announces upcoming anticipated milestones
Premium
The Fly
Outlook Therapeutics announces upcoming anticipated milestones
8d ago
OTLK
Outlook Therapeutics Secures Funding and Board Restructures
Premium
Company Announcements
Outlook Therapeutics Secures Funding and Board Restructures
21d ago
8K
OTLK
Outlook Therapeutics appoints Sukhtian as Chairman of the board of directors
PremiumThe Fly
Outlook Therapeutics appoints Sukhtian as Chairman of the board of directors
22d ago
OTLK
Outlook Therapeutics announces presentation of data from NORSE EIGHT
PremiumThe Fly
Outlook Therapeutics announces presentation of data from NORSE EIGHT
30d ago
OTLK
Outlook Therapeutics enters into agreement for warrant inducement transaction
PremiumThe Fly
Outlook Therapeutics enters into agreement for warrant inducement transaction
1M ago
OTLK
Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
PremiumThe Fly
Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
1M ago
OTLK
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
FATE
OTLK
Outlook Therapeutics Faces Business Risks from Third-Party Manufacturing Dependencies
Premium
Company Announcements
Outlook Therapeutics Faces Business Risks from Third-Party Manufacturing Dependencies
2M ago
OTLK
Outlook Therapeutics Reports 2024 Financial Results
Premium
Company Announcements
Outlook Therapeutics Reports 2024 Financial Results
2M ago
OTLK
Netflix draws big viewership for NFL Christmas games: Morning Buzz
PremiumThe Fly
Netflix draws big viewership for NFL Christmas games: Morning Buzz
2M ago
BA
EH
Outlook Therapeutics reports FY24 EPS ($4.06) vs. ($4.72) last year
PremiumThe Fly
Outlook Therapeutics reports FY24 EPS ($4.06) vs. ($4.72) last year
2M ago
OTLK
Outlook Therapeutics announces upcoming anticipated milestones
PremiumThe Fly
Outlook Therapeutics announces upcoming anticipated milestones
2M ago
OTLK
Outlook Therapeutics provides ONS-5010/LYTENAVA update
PremiumThe Fly
Outlook Therapeutics provides ONS-5010/LYTENAVA update
2M ago
OTLK
OTLK Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsOTLK Upcoming Earnings Report: What to Expect?
2M ago
OTLK
Outlook Therapeutics to reduce workforce by 23%, streamline operations
Premium
The Fly
Outlook Therapeutics to reduce workforce by 23%, streamline operations
2M ago
OTLK
Outlook Therapeutics announces NICE recommendation of LYTENAVA
Premium
The Fly
Outlook Therapeutics announces NICE recommendation of LYTENAVA
3M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >